Menu
Menu
Menu
Pharmacovigilance ensures the rigorous testing of clinical drugs to improve patient care and reduce the risk of negative side effects. Present throughout the drug lifecycle, PV certifies whether a drug works and if it is safe to use.
Brilliant has a pharmacovigilance system and maintains an adverse event reporting database and procedures to compile adverse event information and ensure compliance regulations.
Patient health and ensuring safety of Brilliant products is our top priority.
In order for us to monitor and assess the ongoing safety of our products, Brilliant Pharma has program for reporting serious reactions, product quality problems, therapeutic inequivalence/failure, and product use errors with human medical products, including all types of its products.
we encourage patients and healthcare professionals to report suspected adverse events”
“Adverse effects” or “Adverse events” refer to the unintended or undesirable events subsequent to use of a medicine.
If you believe you have experienced a side effect from one of our medicines, please take the following actions:
Contact your doctor, pharmacist or nurse who can then notify Brilliant
Brilliant can be contacted through the following channels
